drugset / Trial / NCT03715140

Crucumin Effects on the Immune System in Osteoarthritis Patients

NCT03715140 ↗

Phase 3 Unknown 30 enrolled Mashhad University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study, the effects of crucumin on cellular and humoral immune system in patients with osteoarthritis will be investigated. Concentration of CXCL8, April, CX3CL1 and IL-17 will be evaluated with ELISA. TH-1, TH-17, TReg and Ly.B cells count will be measured by Flowcytometry. MicroRNA-720, MicroRNA-155, MicroRNA-16 and MicroRNA-146a gene expression will be measured with Real Time PCR technique.

Timeline

Start
2019-05-01
Primary completion
2020-09-21
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Crucumin Unknown 80 mg —

Indications